Abstract
Objective
To evaluate the effectiveness of a multilevel intervention using national partnerships
on human papillomavirus (HPV) vaccination rates.
Methods
The American Cancer Society's Vaccinate Adolescents against Cancer program is a multilevel
intervention focusing on systems and providers. The 2017 cohort introduced national
partnerships to deliver intervention elements and Maintenance of Certification and
continuing medical education credits for physicians. Eleven federally qualified health
center (FQHC) systems completed interventions in 2017. Interventions included provider
training and ≥1 other evidence-based systems improvement. We compared adolescent vaccination
rates in the preintervention period (2016) and intervention period (2017) among adolescents
who turned 13 during the calendar year. Intervention effectiveness was assessed using
repeated measures paired t tests and Cohen's d effect size for vaccination rate change.
Results
All FQHC systems implemented provider training plus an average of 2.3 additional systems
improvements. Series initiation increased by an average of 23.6 percentage points
(47.2%–70.8%). HPV completion rates increased by an average of 22.7 percentage points
(24.6%–46.3%). Meningococcal and Tdap vaccination rates increased by 23.3 and 25.9
percentage points respectively (47.9%–71.2% and 48.8%–74.7%). All changes were statistically
significant (all P < .05) and indicated large effect sizes (Cohen's d3 1.15). Among clinicians completing postintervention surveys, 90% reported making
changes to their health care system or direct patient care based on what they had
learned.
Conclusions
Multilevel interventions focusing on provider training and systems changes can substantially
improve on-time adolescent vaccination coverage and can be successfully performed
using national partnerships and a train-the-trainer model.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic PediatricsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Recommendationson the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011.MMWR Morb Mortal Wkly Rep. 2011; 60: 1705-1708
- Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices.MMWR Morb Mortal Wkly Rep. 2007; 56 (No RR-2)
- National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2019.MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116https://doi.org/10.15585/mmwr.mm6933a1
HealthyPeople2020. Healthy people 2020. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives Accessed July 2, 2019.
- Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.Hum Vaccines Immunother. 2019; : 1-6https://doi.org/10.1080/21645515.2019.1591138
- Factors associated with Medicaid providers’ recommendation of the HPV vaccine to low-income adolescent girls.J Adolesc Health. 2014; 54: 190-196https://doi.org/10.1016/j.jadohealth.2013.08.006
- Provider communication and HPV vaccination: the impact of recommendation quality.Vaccine. 2016; 34: 1187-1192https://doi.org/10.1016/j.vaccine.2016.01.023
- Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.Vaccine. 2011; 29: 8634-8641
- Effectiveness and net cost of reminder/recall for adolescent immunizations.Pediatrics. 2012; 129: e1437-e1445https://doi.org/10.1542/peds.2011-1714
- A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents.Acad Pediatr. 2013; 13: 204-213https://doi.org/10.1016/j.acap.2013.01.002
- Simple and elaborated clinician reminder prompts for human papillomavirus vaccination: a randomized clinical trial.Acad Pediatr. 2018; 18: S66-S71https://doi.org/10.1016/j.acap.2017.11.002
- Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.Pediatrics. 2014; 134: e666-e674https://doi.org/10.1542/peds.2014-0442
- Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers.Acad Pediatr. 2018; 18: S79-S84https://doi.org/10.1016/j.acap.2017.11.001
- Results of a multilevel intervention trial to increase human papillomavirus (HPV) vaccine uptake among adolescent girls.Cancer Epidemiol Biomarkers Prev. 2016; 25: 593-602https://doi.org/10.1158/1055-9965.EPI-15-1243
- Improving HPV vaccination rates: a stepped-wedge randomized trial.Pediatrics. 2020; 146https://doi.org/10.1542/peds.2019-2737
- The long-term impact of a performance improvement continuing medical education intervention on osteoporosis screening.J Contin Educ Health Prof. 2013; 33: 206-214https://doi.org/10.1002/chp.21200
- Improving HPV vaccination rates using maintenance-of-certification requirements.Pediatrics. 2016; 137e20150675https://doi.org/10.1542/peds.2015-0675
Research Tested Intervention Program. DOSE HPV: development of systems and education for HPV vaccination. Available at: https://rtips.cancer.gov/rtips/programDetails.do?programId=25930477. Accessed January 3, 2021.
- Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.Vaccine. 2014; https://doi.org/10.1016/j.vaccine.2014.11.021
IHI. Institute for Healthcare Improvement. Available at: http://www.ihi.org/about/Pages/ScienceofImprovement.aspx Accessed January 3, 2021.
- Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review.JAMA Pediatr. 2015; 169: 686https://doi.org/10.1001/jamapediatrics.2015.0310
- Stata Statistical Software: Release 14.StataCorp LP, College Station, Tex2016
- Effect size calculator.2020 (Available at:)https://memory.psych.mun.ca/models/stats/effect_size.shtmlDate accessed: May 15, 2020
- Interpreting Cohen's d effect size.2020 (Available at:)https://rpsychologist.com/cohend/Date accessed: November 27, 2020
- Increasing provision of adolescent vaccines in primary care: a randomized controlled trial.Pediatrics. 2014; 134: e346-e353https://doi.org/10.1542/peds.2013-4257
- Announcements versus conversations to improve HPV vaccination coverage: a randomized trial.Pediatrics. 2017; 139https://doi.org/10.1542/peds.2016-1764
- Utilizing a train-the-trainer model for multi-site naloxone distribution programs.Drug Alcohol Depend. 2016; 163: 153-156https://doi.org/10.1016/j.drugalcdep.2016.04.007
- Depression screening and interventions for older home health care patients: program design and training outcomes for a train-the-trainer model.Home Health Care Manag Pract. 2011; 23: 435-445https://doi.org/10.1177/1084822311405459
- Train the trainer effectiveness trials of behavioral intervention for individuals with autism: a systematic review.Am J Intellect Dev Disabil. 2014; 119: 436-451https://doi.org/10.1352/1944-7558-119.5.436
- Getting human papillomavirus vaccination back on track: protecting our national investment in human papillomavirus vaccination in the COVID-19 era.J Adolesc Health. 2020; 67: 633-634https://doi.org/10.1016/j.jadohealth.2020.08.013
- Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers.Acad Pediatr. 2018; 18: S79-S84
- National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2017.MMWR Morb Mortal Wkly Rep. 2018; 67: 909-917https://doi.org/10.15585/mmwr.mm6733a1
- National, regional, state,and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016.MMWR Morb Mortal Wkly Rep. 2017; 66: 874-882https://doi.org/10.15585/mmwr.mm6633a2
Article info
Publication history
Published online: May 20, 2021
Accepted:
May 13,
2021
Received:
January 4,
2021
Footnotes
The authors have no conflicts of interest to disclose.
Identification
Copyright
© 2021 Published by Elsevier Inc. on behalf of Academic Pediatric Association
